New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2013
09:01 EDTNNVCNanoViricides estimates funding is sufficient for about two years of operations
NanoViricides estimates that this funding is sufficient for approximately two years worth of operations. The available funding is estimated to be sufficient for initial human clinical trials of FluCide and possibly of DengueCide as well, depending upon several factors outside of the company’s control.
News For NNVC From The Last 14 Days
Check below for free stories on NNVC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NNVC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use